Xrcc2 deficiency sensitizes cells to apoptosis by MNNG and the alkylating anticancer drugs temozolomide, fotemustine and mafosfamide (Q46812548)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Xrcc2 deficiency sensitizes cells to apoptosis by MNNG and the alkylating anticancer drugs temozolomide, fotemustine and mafosfamide |
scientific article |
Statements
1 reference
Xrcc2 deficiency sensitizes cells to apoptosis by MNNG and the alkylating anticancer drugs temozolomide, fotemustine and mafosfamide (English)
1 reference
Roman Tsaryk
1 reference
Kerstin Fabian
1 reference
John Thacker
1 reference
Bernd Kaina
1 reference
18 November 2005
1 reference
1 reference
239
1 reference
2
1 reference
305-313
1 reference